問卷

TPIDB > Search Result

Search Result

篩選

List

3348Cases

2019-09-01 - 2024-12-31

Phase I/II

A Phase 1/2 Dose Escalation and Dose Expansion Study of BA3021 in Patients With Advanced Solid Tumors
  • Condition/Disease

    Advanced Solid Tumors

  • Test Drug

    BA3021

Participate Sites
4Sites

Recruiting4Sites

2019-05-01 - 2023-08-25

Phase II/III

A Phase 2/3 Study of AMG531 in Patients With Aplastic Anemia Previously Untreated With Immunosuppressive Therapy
  • Condition/Disease

    Aplastic Anemia

  • Test Drug

    AMG531

Participate Sites
5Sites

Terminated5Sites

2019-09-15 - 2024-01-30

Phase III

A Phase 3, Randomized, Placebo-Controlled, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Etrasimod for Induction and Maintenance Treatment in Subjects with Moderately to Severely Active Ulcerative Colitis
  • Condition/Disease

    Moderately to Severely Active Ulcerative Colitis

  • Test Drug

    Etrasimod

Participate Sites
7Sites

Recruiting6Sites

Terminated1Sites

2019-08-01 - 2025-01-31

Phase I/II

A Phase I/II, Open-Label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics and Anti-tumor Efficacy of DZD9008 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) With EGFR or HER2 Mutation
  • Condition/Disease

    Non-Small Cell Lung Cancer

  • Test Drug

    DZD9008

Participate Sites
7Sites

Not yet recruiting5Sites

Recruiting2Sites

2021-08-01 - 2029-12-31

Phase III

  • Condition/Disease

  • Test Drug

Participate Sites
5Sites

Recruiting5Sites

2022-01-01 - 2025-02-28

Phase II

  • Condition/Disease

  • Test Drug

Participate Sites
2Sites

Recruiting2Sites

2021-05-01 - 2024-12-31

Phase II

  • Condition/Disease

  • Test Drug

Participate Sites
5Sites

Not yet recruiting1Sites

Recruiting4Sites

2021-06-01 - 2026-02-01

Phase I/II

  • Condition/Disease

  • Test Drug

Participate Sites
6Sites

Recruiting6Sites

2021-03-01 - 2023-12-29

Phase III

  • Condition/Disease

  • Test Drug

Participate Sites
7Sites

Recruiting6Sites

Terminated1Sites

2021-03-01 - 2023-11-27

Phase III

  • Condition/Disease

  • Test Drug

Participate Sites
7Sites

Recruiting7Sites